Dysregulation of S6K1 activity has been linked to several diseases. In cancer, overactivation of S6K1 leads to uncontrolled cell growth and proliferation. In diabetes, altered S6K1 signaling affects insulin sensitivity and glucose homeostasis. Additionally, aberrant S6K1 activity has been implicated in neurodegenerative diseases, where it may contribute to neuronal cell death and dysfunction.
